These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3303481)
1. The effect of dapsone-pyrimethamine on immunoglobulin concentrations in malaria chemoprophylaxis. Ti TY; Jacob E; Wee YJ Trans R Soc Trop Med Hyg; 1987; 81(2):245-6. PubMed ID: 3303481 [TBL] [Abstract][Full Text] [Related]
2. Sensitivity of Plasmodium falciparum to Maloprim after five years of targetted chemoprophylaxis in a rural area of The Gambia. Allen SJ; Otoo LN; Cooke GA; O'Donnell A; Greenwood BM Trans R Soc Trop Med Hyg; 1990; 84(5):666-7. PubMed ID: 2278063 [No Abstract] [Full Text] [Related]
3. A comparative study of Lapudrine (chlorproguanil) and Maloprim (pyrimethamine and dapsone) as chemoprophylactics against malaria in Gambian children. Greenwood BM; Greenwood AM; Smith AW; Menon A; Bradley AK; Snow RW; Sisay F; Bennett S; Watkins WM; N'Jie AB Trans R Soc Trop Med Hyg; 1989; 83(2):182-8. PubMed ID: 2692227 [TBL] [Abstract][Full Text] [Related]
4. The effect of malarial chemoprophylaxis on immunoglobulin levels of pregnant Nigerian women and the newborn. Ibeziako PA; Williams AI Br J Obstet Gynaecol; 1980 Nov; 87(11):976-82. PubMed ID: 7437370 [TBL] [Abstract][Full Text] [Related]
5. Chemoprophylaxis against malaria in Papua New Guinea: a trial of amodiaquine and a combination of dapsone and pyrimethamine. Vrbova H; Gibney S; Gibson FD; Jolley D; Heywood PF; Stace J; Trenholme KR; Alpers MP P N G Med J; 1992 Dec; 35(4):275-84. PubMed ID: 1341089 [TBL] [Abstract][Full Text] [Related]
6. Inadequate prophylaxis of Plasmodium falciparum malaria with once-a-week Maloprim therapy. Cook IF; McGregor JW Med J Aust; 1982 Dec 11-25; 2(12):563-4. PubMed ID: 6761562 [No Abstract] [Full Text] [Related]
8. Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Menendez C; Kahigwa E; Hirt R; Vounatsou P; Aponte JJ; Font F; Acosta CJ; Schellenberg DM; Galindo CM; Kimario J; Urassa H; Brabin B; Smith TA; Kitua AY; Tanner M; Alonso PL Lancet; 1997 Sep; 350(9081):844-50. PubMed ID: 9310602 [TBL] [Abstract][Full Text] [Related]
9. Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis. Otoo LN; Riley EM; Menon A; Byass P; Greenwood BM Trans R Soc Trop Med Hyg; 1989; 83(6):778-82. PubMed ID: 2515634 [TBL] [Abstract][Full Text] [Related]
10. [Drug resistance of Plasmodium falciparum and Plasmodium vivax strains in Cambodia (Cardamone Massif). Morphological characteristics of Plasmodium vivax]. Lapierre J; Coquelin B; Galal AA; Dupouy-Camet J; Faurant C; Tourte-Schaefer C; Ancelle T; Heyer F Med Trop (Mars); 1984; 44(4):339-49. PubMed ID: 6394948 [TBL] [Abstract][Full Text] [Related]
11. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin response in malaria in Ethiopia: association of splenomegaly with increased concentration of IgM. Watkins RP; Butler WT Proc Soc Exp Biol Med; 1972 Nov; 141(2):708-11. PubMed ID: 4629090 [No Abstract] [Full Text] [Related]
13. ELISA tests for dapsone and pyrimethamine and their application in a malaria chemoprophylaxis programme. Greenwood BM; Greenwood AM; Bradley AK; Shenton FC; Smith AW; Snow RW; Williams K; Eggelte TA; Huikeshoven H; de Wit M Bull World Health Organ; 1986; 64(6):909-16. PubMed ID: 3493860 [TBL] [Abstract][Full Text] [Related]
14. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial. Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409 [TBL] [Abstract][Full Text] [Related]
16. Immunity to malaria in young Gambian children after a two-year period of chemoprophylaxis. Otoo LN; Snow RW; Menon A; Byass P; Greenwood BM Trans R Soc Trop Med Hyg; 1988; 82(1):59-65. PubMed ID: 3051550 [TBL] [Abstract][Full Text] [Related]
17. Malaria chemoprophylaxis--which drug? Biddulph J P N G Med J; 1983 Jun; 26(2):127-30. PubMed ID: 6388184 [No Abstract] [Full Text] [Related]
18. Use of bacterial surrogates as a tool to explore antimalarial drug interaction: Synergism between inhibitors of malarial dihydrofolate reductase and dihydropteroate synthase. Talawanich Y; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y Acta Trop; 2015 Sep; 149():64-9. PubMed ID: 25997881 [TBL] [Abstract][Full Text] [Related]
19. Immunological evaluation of cell-mediated and humoral immunity in Thai patients with cerebral and non cerebral Plasmodium falciparum malaria: II. Evolution of serum levels of immunoglobulins, antimalarial antibodies, complement fractions and alpha interferon. Fribourg-Blanc A; Druilhe P; Brasseur P; Rhodes-Feuillette A; Ballet JJ; Tharavanij S Southeast Asian J Trop Med Public Health; 1985 Jun; 16(2):307-13. PubMed ID: 3906923 [TBL] [Abstract][Full Text] [Related]
20. Some pharmacological aspects of antimalarial drugs. Botha D S Afr Med J; 1974 Jun; 48(29):1263-5. PubMed ID: 4607434 [No Abstract] [Full Text] [Related] [Next] [New Search]